Drug Carriers

Subscribe to Selected New Research on Drug Carriers

337 relevant articles (17 outcomes, 36 trials/studies) found for this Bio-Agent

Description: Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.

Also Known As:

Drug Carrier

Relationship Network

Bio-Agent Context: Research Results

Pharmaceutical Preparations

Chemical Actions and Uses

Specialty Uses of Chemicals

Drug Delivery Systems

Drug Carriers: 337

Dendrimers: 162

Nanocapsules: 57

Experts

1.	Scott, Robert C: 2 articles (01/2008 - 03/2007)
2.	Kiani, Mohammad F: 2 articles (01/2008 - 03/2007)
3.	Wang, Bin: 2 articles (01/2008 - 03/2007)
4.	Pattillo, Christopher B: 2 articles (01/2008 - 03/2007)
5.	Bergemann, Christian: 2 articles (05/2006 - 03/2006)
6.	Sharma, Sadhna: 2 articles (10/2005 - 10/2004)
7.	Khuller, G K: 2 articles (10/2005 - 10/2004)
8.	Yu, Peter H F: 1 article (11/2008)
9.	Chen, Cheng: 1 article (11/2008)
10.	Yu, Chung Him: 1 article (11/2008)

Related Diseases

1.	Neoplasms (Cancer) 09/01/2006 - "These results strongly suggest that intratumoral distribution of drug carrier is much more important for therapeutic efficacy than the total accumulation of the anticancer drug in the tumor, and that active delivery of anticancer drugs to angiogenic vessels is useful for cancer treatment." 06/01/1999 - "This new drug carrier named LMBVs, holds promise for targeting and systemic controlled release, which may prove effective in the treatment of various types of cancer." 07/06/2001 - "The in vivo efficacy of these nanoparticles as antitumor drug carriers, was determined by tumor regression and increased survival time as compared to drug conjugate and free drug" 04/01/2008 - "This study demonstrates that various nanosized drug carriers, imaging agents, and viruses could be surface-engineered to enhance their cellular uptake specifically at a low pH microenvironment like solid tumor tissue." 04/01/2007 - "According to the in vitro cytotoxicity studies, we concluded that when MTX was incorporated into the microemulsion (M-MTX), which is a new drug carrier system, it suppresses tumour cell growth on multiple tumor lines" Order ALL the reference details at left...
2.	Infection 09/01/1985 - "The use of SPLVs as a drug carrier has broad application to treatment of infections due to other organisms." 03/01/2007 - "We observed that especially in alkaline medium a high release was found that was convenient for the vaginal infections seen in the alkaline pH. We concluded that W/O/W multiple emulsions were locally effective in vagina and they could be introduced as a new drug carrier system for vaginal delivery." 02/01/1989 - "We report the development of an antiamoebic drug carrier that may be effective against luminal infections" 07/01/2001 - "As a potent drug carrier for systemic fungal infections, amphotericin B(AmB)-phospholipid composite particles (APCPs) were prepared by the spray drying method" 02/01/2001 - "Long-circulating liposomes (LCL) may be used as targeted antimicrobial drug carriers as they localize at sites of infection" Order ALL the reference details at left...
3.	Glioma (Gliomas) 10/01/2000 - "An improved understanding of the vascular microenvironment in gliomas will help in the future to optimize glioma imaging and delivery of vectors for gene therapy or encapsulated drug carriers in patients." 01/01/2004 - "An improved understanding of the vascular microenvironment in gliomas will help in the future to optimize glioma imaging and to improve delivery of vectors for gene therapy or encapsulated drug carriers for pharmacotherapy in patients." 01/01/2008 - "In an attempt to overcome these hurdles, polyether-copolyester (PEPE) dendrimers were evaluated as drug carriers for the treatment of gliomas" 05/01/2005 - "Implanted drug carrier systems for retarded chemotherapy against gliomas are mainly based upon polymers containing nitrosoureas" 09/10/2008 - "Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas." Order ALL the reference details at left...
4.	Atherosclerosis (Atheroma) 07/01/1999 - "This study provides the basis for further study of the DP-LDL complex as a drug-carrier complex for treatment of atherosclerosis." 04/01/2003 - "Since selective delivery of drugs into foam cells in the early stage of atherosclerosis is a useful protocol for antiatherosclerosis treatment, the DP-LDL complex appears to be a potentially useful drug-carrier complex for future antiatherosclerotic therapy." 08/01/2001 - "Therefore, DP-LDL complex may be a good drug-carrier in drug delivery system for atherosclerosis." 04/01/2000 - "This DP-LDL complex has a possibility as a drug-carrier complex for use in atherosclerosis." 01/01/2003 - "To confirm the efficacy of KV-2920-low density lipoprotein (LDL) complex (KV-LDL complex) as a drug-carrier complex on experimental atherosclerosis, we examined its inhibitory effects in vitro and in vivo" Order ALL the reference details at left...
5.	Brain Neoplasms (Brain Tumor) 12/01/1995 - "The authors conclude that the use of long-circulating liposomes as cytotoxic drug carriers in brain tumor results in enhanced drug exposure and improved therapeutic activity, with equal effectiveness against early small- and large-sized brain tumors." 07/01/2005 - "mAb 2C5 specifically recognizes brain tumor cells and can serve as a ligand to target drug carriers such as liposomes to brain tumor cells in vivo." 01/15/1993 - "The administration of drugs directly into the central nervous system using polymers as drug carriers may improve the treatment of malignant brain tumors" 04/01/1990 - "These results indicate that liposomes can penetrate the blood-brain barrier and hold promise as drug carriers in the treatment of brain tumors with cisplatin." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Liposomes (Liposome)
2.	Antineoplastic Agents (Antineoplastics)
3.	Lipoproteins (Lipoprotein)
4.	Glycoproteins (Glycoprotein)
5.	Daunorubicin (Cerubidine)
6.	Glutamic Acid (Glutamate)
7.	alpha-Fetoproteins (AFP)
8.	polylactic acid-polyglycolic acid copolymer (PLGA)
9.	Emulsions
10.	Iodized Oil (Lipiodol)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Microspheres (Microsphere)
3.	Immunotherapy
4.	Arthroplasty
5.	Therapeutics

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 18530 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>